Apogenics Inc - Dallas, Texas 75254

Apogenics Inc is categorized under Business Management Consultants in Dallas, TX .

Business Name: Apogenics Inc
Contact Person: David Galardi
Address: 14881 Quorum Drive # 300, Dallas, Texas 75254
Phone Number: (972) 342-6905
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Management Consultants
SIC Code: 8742
NAICS Code: 541611
Share This Business:
Related Businesses: Manor Group LLC - Dallas, TX 75254
Sscg LLC - Dallas, TX 75254
Gregory Michael - Dallas, TX 75254
Le Huynh Inc - Dallas, TX 75254
Miller And Assoc - Dallas, TX 75254
Primus Valuation Group, LLC - Dallas, TX 75254
Robron Management Company LLC - Dallas, TX 75254
Robert Manna Associates - Dallas, TX 75254
Intersect Group - Dallas, TX 75254
50 Hoops - Dallas, TX 75254
D-Quattro L L C - Dallas, TX 75254
Morgan Kopper Inc - Dallas, TX 75254
Network Business Consulting - Dallas, TX 75254
Best At It Inc - Dallas, TX 75254
Wigo Partners LLC - Dallas, TX 75254
North Highland CO - Dallas, TX 75254
Cowlishaw & Associates Inc - Dallas, TX 75254
Raintree Partners - Dallas, TX 75254
Meritax - Dallas, TX 75254
Avondale Wealth Management LLC - Dallas, TX 75254

The company Apogenics Inc provides B2B services in the form of Business Management Consultants from its single location in Texas. 1 to 4 employees work for Apogenics Inc, and the business now earns $100.000 to $499.999 per annum.

Apogenics Inc was launched in 2012 and is classified under SIC code and category 8742 , and NAICS number and grouping 541611 . To contact Apogenics Inc, please call David Galardi with the phone number (972) 342-6905 or visit its single location at 14881 Quorum Drive # 300 in Dallas, Texas 75254.

The location of the single location can also be found using the coordinates 32.9528,-96.826174. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.